Acyl-CoA oxidase 2 is an enzyme that in humans is encoded by the gene ACOX2. Like its relatives ACOX1 and ACOX3, this enzyme is involved in the process of breaking down lipids in the peroxisomes (called peroxisomal beta oxidation). ACOX2 specifically acts on branched-chain fatty acids and intermediates of bile acid metabolism, and displays some overlap with ACOX3 in the types of lipids it acts on.
Peroxisomal beta oxidation is a process that breaks down certain lipids like very long chain fatty acid (22 or more carbons), branched-chain fatty acid, and some bile acid intermediates. Chemically, this follows essentially the same steps as mitochondrial beta oxidation but utilizes different enzymes.
Acyl-CoA oxidases (EC 1.3.3.6), like ACOX2, serve as the peroxisomal analogues to mitochondrial acyl-CoA dehydrogenase, and catalyze reactions of the form:
This differs from the mitochondrial reaction in its production of hydrogen peroxide, which is a characteristic feature of peroxisome pathways that gives the organelle its name.
ACOX2 differs from the other two types of acyl-CoA oxidase found in humans by the specific lipids it acts on. In the liver, it is part of peroxisomal bile acid synthesis through its action of C27-bile acid intermediates. In brown adipose tissue, it acts on monomethyl branched-chain fatty acids, which is part of how the body adapts to cold temperatures.
Pathogenic mutations in ACOX2 are associated with a bile acid synthesis disorder that causes an accumulation of C27 bile acids and high levels of transaminase in the blood, called congenital bile acid synthesis defect-6 (CBAS6). Some of those affected have also had more serious symptoms, but whether there is a causal link is not clear due to confounding factors.